[Metabolic syndrome and chronic disease of the kidneys: the role of age-related androgenic deficiency. New approaches to treatment (review)].
Novikova
M S
MS
Kalinchenko
S Iu
SIu
Borisov
V V
VV
D000367:Age Factors; D000728:Androgens / Q000172:deficiency*; D050171:Dyslipidemias / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000453:epidemiology*; D007783:Lactones / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000453:epidemiology* / Q000378:metabolism; D000077403:Orlistat; D011376:Progesterone-Binding Globulin / Q000172:deficiency; D013739:Testosterone / Q000031:analogs & derivatives* / Q000172:deficiency / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D017539:Tunica Intima / Q000502:physiology
D000728:Androgens; D000960:Hypolipidemic Agents; D007783:Lactones; D011376:Progesterone-Binding Globulin; D014409:Tumor Necrosis Factor-alpha; D013739:Testosterone; D000077403:Orlistat; C010792:testosterone undecanoate